Asset Management One Co. Ltd. Has $23 Million Position in Axon Enterprise, Inc $AXON

Asset Management One Co. Ltd. grew its holdings in Axon Enterprise, Inc (NASDAQ:AXON) by 4.1% in the third quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 32,047 shares of the biotechnology company’s stock after buying an additional 1,273 shares during the quarter. Asset Management One Co. Ltd.’s holdings in Axon Enterprise were worth $22,998,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also added to or reduced their stakes in the company. Brighton Jones LLC bought a new position in shares of Axon Enterprise in the fourth quarter worth about $480,000. Axiom Investors LLC DE acquired a new stake in shares of Axon Enterprise in the first quarter valued at approximately $93,088,000. Hancock Whitney Corp raised its position in Axon Enterprise by 7.6% in the 1st quarter. Hancock Whitney Corp now owns 424 shares of the biotechnology company’s stock worth $223,000 after purchasing an additional 30 shares during the last quarter. NewEdge Advisors LLC raised its position in Axon Enterprise by 41.1% in the 1st quarter. NewEdge Advisors LLC now owns 2,294 shares of the biotechnology company’s stock worth $1,207,000 after purchasing an additional 668 shares during the last quarter. Finally, UniSuper Management Pty Ltd lifted its holdings in Axon Enterprise by 9.8% during the 1st quarter. UniSuper Management Pty Ltd now owns 6,453 shares of the biotechnology company’s stock worth $3,394,000 after buying an additional 577 shares in the last quarter. Institutional investors and hedge funds own 79.08% of the company’s stock.

Analyst Ratings Changes

AXON has been the subject of a number of recent research reports. Piper Sandler dropped their target price on Axon Enterprise from $893.00 to $753.00 and set an “overweight” rating for the company in a research report on Wednesday, November 5th. Morgan Stanley dropped their price objective on Axon Enterprise from $760.00 to $713.00 and set an “overweight” rating for the company in a report on Wednesday, December 17th. Needham & Company LLC restated a “buy” rating and set a $870.00 target price on shares of Axon Enterprise in a research report on Wednesday, September 24th. Wall Street Zen lowered shares of Axon Enterprise from a “hold” rating to a “sell” rating in a research note on Saturday, November 8th. Finally, UBS Group dropped their price target on shares of Axon Enterprise from $840.00 to $610.00 and set a “neutral” rating for the company in a research note on Wednesday, November 5th. Fourteen research analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the company. Based on data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $802.71.

Insider Activity

In other news, insider Jeffrey C. Kunins sold 1,797 shares of Axon Enterprise stock in a transaction dated Tuesday, December 2nd. The stock was sold at an average price of $539.23, for a total transaction of $968,996.31. Following the transaction, the insider owned 83,485 shares in the company, valued at $45,017,616.55. The trade was a 2.11% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, CFO Brittany Bagley sold 2,500 shares of the business’s stock in a transaction that occurred on Monday, November 10th. The shares were sold at an average price of $610.00, for a total value of $1,525,000.00. Following the completion of the transaction, the chief financial officer owned 91,092 shares of the company’s stock, valued at $55,566,120. This represents a 2.67% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. In the last quarter, insiders sold 50,540 shares of company stock valued at $28,494,638. Company insiders own 4.40% of the company’s stock.

Axon Enterprise Stock Up 4.9%

Shares of NASDAQ AXON opened at $591.16 on Tuesday. Axon Enterprise, Inc has a 52-week low of $469.24 and a 52-week high of $885.91. The company has a debt-to-equity ratio of 0.57, a quick ratio of 2.89 and a current ratio of 3.12. The stock has a market cap of $46.65 billion, a P/E ratio of 187.08, a P/E/G ratio of 17.74 and a beta of 1.41. The firm has a 50 day moving average price of $582.72 and a 200 day moving average price of $691.94.

Axon Enterprise (NASDAQ:AXON) last announced its quarterly earnings results on Wednesday, November 5th. The biotechnology company reported $1.17 earnings per share for the quarter, missing analysts’ consensus estimates of $1.63 by ($0.46). Axon Enterprise had a return on equity of 4.29% and a net margin of 10.05%.The firm had revenue of $710.64 million for the quarter, compared to the consensus estimate of $704.83 million. During the same period in the prior year, the business earned $1.45 earnings per share. The company’s revenue for the quarter was up 30.6% compared to the same quarter last year. Analysts expect that Axon Enterprise, Inc will post 5.8 EPS for the current year.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops technology and weapons systems for public safety and law enforcement agencies, combining hardware, software and cloud services. The company’s hardware portfolio includes conducted energy weapons (commonly known as TASER devices), body-worn cameras and in-car camera systems. Axon pairs these devices with a suite of connected products and accessories designed to capture, store and manage field evidence.

Beyond hardware, Axon operates a subscription-based software platform for digital evidence management, evidence review and records management.